Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · Jan 2013
ReviewClass-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.
To provide an update on the recently approved class-wide risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioids and to discuss the potential impact on pharmacy practice. ⋯ Although the changing requirements for prescribing ER/LA opioids will not have a direct effect on pharmacist workflow, the pharmacist-patient interaction remains critical for overall risk reduction with this class of medication.